Celanese Co. (NYSE: CE) had its price target raised by analysts at Robert W. Baird from $165.00 to $180.00. They now have an "outperform" rating on the stock.
Medical Polymer Market worth $60.5 billion by 2029 - Exclusive Report by MarketsandMarkets™ [Yahoo! Finance]
Celanese Receives American Chemistry Council’s 2024 Sustainability Leadership Award for Achievements in Circularity
Celanese Co. (NYSE: CE) had its price target raised by analysts at Mizuho from $161.00 to $173.00. They now have a "neutral" rating on the stock.
Celanese (CE) Reports Q1 Earnings: What Key Metrics Have to Say [Yahoo! Finance]